State Stem Cell Agency ICOC Agenda 3-12-09

Return to CIRM Meetings and Events

Regular Meeting of the

INDEPENDENT CITIZENS OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and

The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
 

Open Session
  1. Call to Order.
  2. Pledge of Allegiance.
  3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

 

Open Session
  1. Approval of minutes from August 12-13, September 25th and December 9-10 , 2008 meetings and January 29th-30th, 2009 ICOC meetings.
  2. Adoption of Regulation 100502, Definition of “California Supplier.”
  3. Initiation of the OAL process to amend CIRM Medical and Ethical Standards regulations regarding oversight and consent requirements for use of blastocysts and somatic cells.
  4. Adoption of Regulation 100081, “Exemption” Petition for hESC line.

 

REPORTS
  1. Chairman’s Report.
  2. President’s Report.
    1. Audited Financial Statements 07-08
    2. Auditors Report to Management 07-08

 10.  Update on private bond placement program.

 

CLOSED SESSION

   11. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section

         125290.30(d) (3) (D)).

Public report of any action taken, if necessary, during closed session.

 

ACTION ITEMS

   12. Consideration of amendments to ICOC bylaws and Internal Governance Policy regarding Vice-Chair(s).

   13. Consideration of amendment to lower CIRM salary range for Vice-Chair.

   14. Consideration of election of Vice-Chair(s).

   15. Consideration of staff recommendations on research funding priorities.

   16. Consideration of funding for approved Bridges to Stem Cell Research grant applications.

   17. Consideration of funding for approved Training Program II grant applications.

   18. Consideration of amendment to CIRM travel policy with regard to meal reimbursement

   19. Consideration of new scientific members for Grants Working Group.

   20. Consideration of amendment to contract with Remcho, Johansen and Purcell.

 

DISCUSSION ITEM

   21. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on

         the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 

 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 

Date Published: March 23, 2009
Last Modified: April 5, 2017